- Diverse Galactooligosaccharides Differentially Reduce LPS-Induced Inflammation in Macrophages
Congcong Sun et al, 2022, Foods CrossRef - Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells
Jin-Mei Yao et al, 2023, Free Radical Biology and Medicine CrossRef - Akkermansia muciniphila - A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease
Goutam Banerjee et al, 2024, Current Pharmaceutical Biotechnology CrossRef - Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD
Ayushi Purohit et al, 2024, iScience CrossRef - Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna et al, 2024, Molecules CrossRef - Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
Xinlu Cao et al, 2023, Metabolites CrossRef - Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
Salvatore Pezzino et al, 2022, Biology CrossRef - Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran et al, 2023, Reviews in Endocrine and Metabolic Disorders CrossRef - Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Chunye Zhang et al, 2023, Exploration of Digestive Diseases CrossRef - Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease
Yan Jiang et al, 2024, Phytomedicine CrossRef - Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
Mira Thing et al, 2024, BMC Gastroenterology CrossRef - Current Status of Research on Cardiovascular Risk in Patients with Non-Alcoholic Fatty Liver Disease
·巴哈提 娜迪热, 2023, Advances in Clinical Medicine CrossRef - What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Giovanni Tarantino et al, 2024, Lipids in Health and Disease CrossRef